1. NLRP3 inhibitors as potential therapeutic agents for treatment of inflammatory bowel disease;Agampodi Promoda;Curr. Pharm. Des.,2017
2. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases;Coll;Nat. Med.,2015
3. Clinicopathologic study of dextran sulfate sodium experimental murine colitis;Cooper;Laboratory investigation; a journal of technical methods and pathology,1993
4. Initiation and perpetuation of NLRP 3 inflammasome activation and assembly;Elliott;Immunol. Rev.,2015
5. Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis;He;Sci. Rep.,2016